COLD: Study of Oncological Outcomes of D3 Lymph Node Dissection in Colon Cancer

Trial Overview

AcronymCOLD
NumberNCT03009227
Protocol Linkhttps://www.dropbox.com/s/znqwxo2ygwk6kct/Protocol_COLD_1.1_eng.pdf?dl=0
Public Trial Registry Linkhttps://clinicaltrials.gov/ct2/show/NCT03009227
StatusOpen/recruiting
CategoryColorectal Cancer - Colonic Specific
Treatment CourseSurgery

Trial Description

The design involves random allocation of eligible patients undergoing colonic resection to D3 or D2 lymph node dissection group in 1:1 ratio. A 3 year accrual period and 5 year follow up is planned. The intent-to-treat principle is used for the data analysis. Primary endpoint is overall survival

Chief Investigator

Aleksei Karachun
Professor
Profile Link

Lead Centre

National Medical Research Center named after N.N. Petrov
ul. Leningradskaya, house 68
St Petersburg
197758
Russia
Website

Collaboration and Funding

Collaborative Sites

Additional Information

Full Research Summary
ESCP Affiliates